Veterinary Vaccines Market to Grow at a Robust Pace During 2021-2026

October 26^th,2021/IndustryNewsGlobal/ -- This new report from Stratview Research analyses the Flexible Workspace Market over the trend period from 2016 to 2019 and forecast period from 2022 to 2026. The insights of the report shall enable informed decision making and strategy formulation for the near future to capitalize on the opportunities.

Flexible Workspace Market Overview:

The sudden outbreak of the COVID-19 has led to unforeseen fluctuations across many industries and the Flexible Workspace Market is no different. Derived from the previous market scenario, the Flexible Workspace Market is expected to grow from USD 33.23 billion in 2020 to USD 73.03 billion by 2026 at a CAGR of 14.0% during the forecast period but with the global crisis in action, the growth curve has deviated from its expected path and exhibits an uncertain trajectory at present. 

Key Players:

• WeWork (The U.S),
• Workspace (UK),
• Awfis (India),
• SMARTWORKS (India),
• BizSpace (UK),
• Servcorp (Australia),
• IWG (Luxembourg),
• Garage Society (India),
• The Great Room (Singapore), and
• Pacific Workplaces (The U.S).

The Flexible Workspace Market is segmented by–

• By Type (Co-working, Open Office, Hot Desks, Serviced Office, Manufacturing Space, Virtual Office),
• By End-User (IT, Education, Media, Manufacturing) 
• By Region (North America, Europe, Asia-Pacific, and Rest of the World).

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/1680/flexible-workspace-market.html#form

Regional analysis:

Among regions, North America is expected to be the largest contributor during the forecast period due to the nationwide availability of cost-effective flexible workspaces and demand for innovative office solutions by the regional businesses.

Asia Pacific is expected to grow with the highest CAGR due to increasing number of small businesses and freelancers in the region who require these kinds of temporary workspaces to do their jobs.

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176

October 25^th,2021/IndustryNewsGlobal/ -- This new report from Stratview Research analyses the Patient Engagement Solutions Market over the trend period from 2016 to 2019 and forecast period from 2022 to 2026. The insights of the report shall enable informed decision making and strategy formulation for the near future to capitalize on the opportunities.

Patient Engagement Solutions Market Overview:

The sudden outbreak of the COVID-19 has led to unforeseen fluctuations across many industries and the Patient Engagement Solutions Market is no different. Derived from the previous market scenario, the Patient Engagement Solutions Market is projected to grow from USD 15.6 billion in 2020 to USD 48.4 billion by 2026 at a CAGR of over 20.8% during the forecast period but with the global crisis in action, the growth curve has deviated from its expected path and exhibits an uncertain trajectory at present. 

Key Players:

• Allscripts Healthcare Solutions (The U.S),
• McKesson Corporation (The U.S),
• Orion Health Ltd. (New Zealand),
• Cerner Corporation (The U.S),
• Phytel Inc. (The U.S),
• Medecision Inc. (The U.S),
• GetWellNetwork Inc. (The U.S),
• YourCareUniverse Inc. (The U.S),
• Lincor Solutions Ltd. (The U.S), and
• Athenahealth, Inc. (The U.S).

The Patient Engagement Solutions Market is segmented by–

• By Delivery Type (Web-based/Cloud-based, On-premise), 
• By Component (Software [Standalone, Integrated),
• By Services (Consulting, Implementation, Education, Others], Hardware), 
• By End-Use (Payers, Providers, Individual Users),
• By Application (Social Management, Health Management, Home Healthcare Management, Financial Health Management), 
• By Therapeutic Area (Chronic diseases [Obesity, Diabetes, Cardiovascular, Others), 
• By Fitness, Women's Health, Mental Health, Others), 
• By Region (North America, Europe, Asia-Pacific, and Rest of the World).

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/1856/patient-engagement-solutions-market.html#form

Regional analysis:

By region, the market in the North America garnered the largest market share of around 39% in 2020 and is estimated to grow at a substantial CAGR during the assessment period.

• This is mainly ascribed to the rising adoption of health and HER and increasing investment in patient engagement software by the major companies.
• Furthermore, rising awareness level along with increasing government spending on the healthcare sector is further expected to proliferate the growth.

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176

October 25^th,2021/IndustryNewsGlobal/ -- This new report from Stratview Research analyses the Sickle Cell Market over the trend period from 2016 to 2019 and forecast period from 2022 to 2026. The insights of the report shall enable informed decision making and strategy formulation for the near future to capitalize on the opportunities.

Sickle Cell Market Overview:

The sudden outbreak of the COVID-19 has led to unforeseen fluctuations across many industries and the Sickle Cell Market is no different. Derived from the previous market scenario, the Sickle Cell Market is estimated to grow from USD xx million in 2020 to USD xx million by 2026 at a healthy CAGR of x% during the forecast period but with the global crisis in action, the growth curve has deviated from its expected path and exhibits an uncertain trajectory at present. 

COVID-19 Impact on Global Sickle Cell Market

The covid-19 outbreak posed significant challenges to the health care system across geographies. It affected the growth of the sickle cell market negatively as patients postponed their appointments due to a rapid surge in covid-19 cases across geographies. Also, supply chain disruptions due to the imposition of lockdown affected the market growth further.

Key Players:

• Bluebird bio, Inc. (The U.S),
• Eli Lilly and Company (The U.S),
• Gilead Sciences, Inc. (The U.S),
• Merck & Co., Inc. (The U.S),
• Novartis International AG (Switzerland),
• Sanofi S.A. (France),
• Baxter International Inc. (The U.S),
• Bristol-Myers Squibb (The U.S),
• Global Blood Therapeutics (The U.S),
• Johnson & Johnson (The U.S),
• Mast Therapeutics (The U.S), and
• Pfizer, Inc. (The U.S).

The Sickle Cell Market is segmented by–

• By Therapy (Bone Marrow Transplant, Medications, Blood Transfusion, Gene Therapy), 
• By End-User (Hospital, Clinic, Home Healthcare),
• Region (North America, Europe, Asia-Pacific, and Rest of the World).

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/1811/sickle-cell-market.html#form

Regional analysis:

The market in North America accounted for the largest share in 2020 and is projected to register significant growth during the review period.

• The regional market growth can be attributed to the availability of required infrastructure and technologies to treat the patients having the sickle disease.
• The market in the Asia-Pacific region is projected to register the fastest growth rate on account of rising consumer awareness and advancement in healthcare infrastructure in developing countries.

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas.

For enquiries,
Contact:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176

October 22nd,2021/IndustryNewsGlobal/ -- This new report from Stratview Research analyses the Autoimmune Disease Diagnosis Market over the trend period from 2015 to 2020 and forecast period from 2021 to 2026. 

he insights of the report shall enable informed decision making and strategy formulation for the near future to capitalize on the opportunities.

Autoimmune Disease Diagnosis Market Overview:

The sudden outbreak of the COVID-19 has led to unforeseen fluctuations across many industries and the Autoimmune Disease Diagnosis Marketis no different. Derived from the previous market scenario, the Autoimmune Disease Diagnosis Market is likely to witness a CAGR of 8.2% during the forecast period but with the global crisis in action, the growth curve has deviated from its expected path and exhibits an uncertain trajectory at present. 

Key Players:

• Abbott Laboratories
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Euroimmun AG
• Grifols S.A.
• Hycor Biomedical Inc.
• Siemens AG
• Thermo Fisher Scientific
• Trinity Biotech plc
• Werfen
• Others

The Autoimmune Disease Diagnosis Market is segmented by–

• byProduct Type (Consumables Assay Kits, Instruments),
• byTest Type (Routine Laboratory Tests, Inflammatory Markers, Autoantibodies Immunologic Tests, and Other Tests),
• byDisease Type (Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjogren’s Syndrome, Thyroiditis, Scleroderma, and Other Diseases),
• byEnd-User Type (Clinical Laboratories, Hospitals, and Others),
• byRegion (North America, Europe, Asia-Pacific, and Rest of the World).

Get access to a deeper coverage of the impact of COVID-19 on this Market here: https://www.stratviewresearch.com/Request-Sample/886/autoimmune-disease-diagnosis-market.html#form

Regional analysis:

In terms of regions, Europe is estimated to remain the largest market during the forecast period due to the rising chronic diseases such as rheumatoid arthritis among the increasing ageing population. Autoimmune diseases affect 5-10% of the population in Europe and North America. The 3TR project (taxonomy, treatments, targets and remission) funded by the EU’s Innovative Medicines Initiative with €80 million for the next seven years to discover biomarkers that can predict which patients will respond best to the treatments for autoimmune diseases is another significant factor contributing to the growth of the region’s market.

About Stratview Research

Stratview Research is a global market intelligence firm providing wide range of services including syndicated market reports, custom research and sourcing intelligence across industries, such as Advanced Materials, Aerospace Defense, Automotive Mass Transportation, Consumer Goods, Construction Equipment, Electronics and Semiconductors, Energy Utility, Healthcare Life Sciences, and Oil Gas.

For enquiries,
Contact:
Stratview Research
E-mail: sales@stratviewresearch.com
Direct: +1-313-307-4176

Oct 25, 2021/IndustryNewsGlobal/ The unexpected shifts in the global markets because of the sudden outbreak of the COVID-19 virus have brought many major and minor tremors to industries of all sizes including the Green Building Materials Market.

It was estimated prior to this unanticipated outbreak that the Green Building Materials Market likely to witness a promising CAGR of 12.4% during the forecast period. With the increasing population and extended life expectancy comes the growing ageing population, which demands for efficient care and comfort. This, along with the rising global health expenditure, rapid growth of implantable devices, and an incessant shift from traditional to advanced wound care products are some key factors adding a stir in the demand for Green Building Materialss, fueling the market’s growth during the forecast period. are some key factors adding a stir in the demand for Green Building Materialss, fueling the market’s growth during the forecast period.

Green building materials are made of renewable sources which can be recycled or reused rather than nonrenewable resources. They are environmentally friendly materials. Majorly used materials are earthen material, engineered wood, bamboo, insulated concrete forms, and many more.

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

Segment Analysis

Based on the end-user industry type, the market is segmented as residential, commercial, institutional and others. The residential segment is expected to remain dominant as well as the fastest-growing segment of the market during the forecast period owing to increasing per capita income of developing countries and shift from conventional buildings to energy-efficient buildings. Additionally, increasing awareness among public regarding usage of environmentally friendly material for building homes has boosted the demand for green building materials in the segment.

In terms of regions, North America is estimated to be the largest green building materials market during the next five years, with the USA, Canada, and Mexico being the major countries offering promising. The growth of the market is owing the, per-capita income of countries, extensive growth of the construction in the region, and presence of a large number of green building materials manufacturers in the region. The green building materials market is mainly driven by increase in population and rise in construction of residential and non-residential buildings.

Key Players:

Key players operating in the global Green Building Materials market are-

• BASF SE
• Binderholz GmbH
• Black Mountain Insulation Limited
• CERTAINTEED
• Chengdu Onekin Green Building Materials Co. Ltd
• DuPont
• ElementalGreen
• Interface Inc
• IsoHemp
• Kingspan Group

Features of the Report

This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools.

The Green Building Materials analysis report discusses the following heads in great detail:

• Market structure: Overview, industry life cycle analysis, supply chain analysis
• COVID-19 Impact Assessment
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors 

Know more about Stratview Research:

Stratview Research is a global market research company and is known to offer custom research reports in varied fields such as aerospace & Defense, Advanced Materials, Aerospace & Defense, Automotive & Mass Transportation, Consumer Goods, Construction & Equipment, Electronics and Semiconductors, Energy & Utility, Healthcare & Life Sciences, and Oil & Gas. Our team makes sure to have deep research about the topics so that the most useful insights can be delivered to the professionals.

Need a detailed report? Get in touch with us: 

Stratview Research

E-mail: sales@stratviewresearch.com

Direct: +1-313-307-4176